Karen L. Smith's Net Worth

$5.9 Million

Who is Karen L. Smith?

Karen L. Smith has an estimated net worth of $5.9 Million. This is based on reported shares across multiple companies, which include Sucampo Pharmaceuticals, Inc., SANGAMO THERAPEUTICS, INC, ANTARES PHARMA, INC., Jazz Pharmaceuticals plc, Emergent BioSolutions Inc., Quince Therapeutics, Inc., Talaris Therapeutics, Inc., ACCELERON PHARMA INC, Aurinia Pharmaceuticals Inc., Skye Bioscience, Inc., and Context Therapeutics Inc..

SEC CIK

Karen L. Smith's CIK is 0001639637

Past Insider Trading and Trends

2021 was Karen L. Smith's most active year for acquiring shares with 15 total transactions. Karen L. Smith's most active month to acquire stocks was the month of May. 2021 was Karen L. Smith's most active year for disposing of shares, totalling 19 transactions. Karen L. Smith's most active month to dispose stocks was the month of March. 2021 saw Karen L. Smith paying a total of $1,939,216.69 for 138,936 shares, this is the most they've acquired in one year. In 2021 Karen L. Smith cashed out on 63,498 shares for a total of $2,899,718.11, their largest year based on trade value.